Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glycosylation of SARS-CoV-2 Steers Evolutionary Outcomes in the Postvaccination Phase.

Literature DB >> 33615193

Glycosylation of SARS-CoV-2 Steers Evolutionary Outcomes in the Postvaccination Phase.

Abstract

There is a need to assess evolutionary outcomes for SARS-CoV-2 in the postvaccination phase. The role of virus glycosylation in deterring the development of vaccine resistance is weighed against the epitopes of extant vaccines and the modulation of induced immune surveillance on antigens containing glycosylation sites.

Entities: Chemical

Year: 2021 PMID： 33615193 PMCID： PMC7887837 DOI： 10.1021/acsptsci.1c00015

Source DB: PubMed Journal: ACS Pharmacol Transl Sci ISSN： 2575-9108

3 in total

1. Monitor for COVID-19 vaccine resistance evolution during clinical trials.

Authors: David A Kennedy; Andrew F Read
Journal: PLoS Biol Date: 2020-11-09 Impact factor: 8.029

2. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.

Authors: Tyler N Starr; Allison J Greaney; Sarah K Hilton; Daniel Ellis; Katharine H D Crawford; Adam S Dingens; Mary Jane Navarro; John E Bowen; M Alejandra Tortorici; Alexandra C Walls; Neil P King; David Veesler; Jesse D Bloom
Journal: Cell Date: 2020-08-11 Impact factor: 41.582

3. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.

Authors: Oliver C Grant; David Montgomery; Keigo Ito; Robert J Woods
Journal: Sci Rep Date: 2020-09-14 Impact factor: 4.379

3 in total

5 in total

Glycosylation of SARS-CoV-2 Steers Evolutionary Outcomes in the Postvaccination Phase.

1. Monitor for COVID-19 vaccine resistance evolution during clinical trials.

2. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.

3. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.

1. Toward the Next-Generation COVID-19 Vaccines That Circumvent Antigenic Drift while Defusing Viral Infection.

2. SARS-CoV-2 Glycosylation Suggests That Vaccines Should Have Adopted the S1 Subunit as Antigen.

3. Identification and characterization of a novel cell binding and cross-reactive region on spike protein of SARS-CoV-2.

Review 4. A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines.

5. IgA Nephropathy After SARS-CoV-2 Vaccination.